Loading
Latest filing published 03 Feb 2022 for Fusion Pharmaceuticals Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by James J. O'Leary, dated 3 February 2022, reporting a share grant in Fusion Pharmaceuticals Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration